Search Results - "Maor, Y"

Refine Results
  1. 1

    Effect of a new insulin treatment regimen on glycaemic control and quality of life of Muslim patients with type 2 diabetes mellitus during Ramadan fast - an open label, controlled, multicentre, cluster randomised study by Shehadeh, N, Maor, Y

    “…We performed a non-inferiority trial comparing insulin detemir (Levemir) and biphasic insulin (NovoMix70) to standard care during Ramadan fast in insulin…”
    Get more information
    Journal Article
  2. 2

    Outcome of carbapenem resistant Klebsiella pneumoniae bloodstream infections by Ben-David, D., Kordevani, R., Keller, N., Tal, I., Marzel, A., Gal-Mor, O., Maor, Y., Rahav, G.

    Published in Clinical microbiology and infection (01-01-2012)
    “…The aim of this study was to evaluate the impact of carbapenem-resistant K. pneumoniae bloodstream infections on mortality. During the study period 42, 68 and…”
    Get full text
    Journal Article
  3. 3

    Liver Injury Induced by Anticancer Chemotherapy and Radiation Therapy by Maor, Y., Malnick, S.

    Published in International Journal of Hepatology (01-01-2013)
    “…Cytotoxic chemotherapy prolongs survival of patients with advanced and metastatic tumors. This is, however, a double-edged sword with many adverse effects…”
    Get full text
    Journal Article
  4. 4

    Endocannabinoid‐like N‐arachidonoyl serine is a novel pro‐angiogenic mediator by Zhang, X, Maor, Y, Wang, JF, Kunos, G, Groopman, JE

    Published in British journal of pharmacology (01-08-2010)
    “…BACKGROUND AND PURPOSE N‐arachidonoyl serine (ARA‐S) is a recently identified endocannabinoid‐like lipid with weak affinity for the fully characterized…”
    Get full text
    Journal Article
  5. 5

    Possible evidence of systemic lupus erythematosus and periodontal disease association mediated by Toll‐like receptors 2 and 4 by Marques, C. P. C., Maor, Y., de Andrade, M. S., Rodrigues, V. P., Benatti, B. B.

    Published in Clinical and experimental immunology (01-02-2016)
    “…Summary Toll‐like receptors (TLRs) participate in the innate immune response and trigger the immune responses of the body. Systemic lupus erythematosus (SLE)…”
    Get full text
    Journal Article
  6. 6

    The decline of anti-drug antibody titres after discontinuation of anti-TNFs: implications for predicting re-induction outcome in IBD by Ben-Horin, S., Mazor, Y., Yanai, H., Ron, Y., Kopylov, U., Yavzori, M., Picard, O., Fudim, E., Maor, Y., Lahat, A., Coscas, D., Eliakim, R., Dotan, I., Chowers, Y.

    Published in Alimentary pharmacology & therapeutics (01-03-2012)
    “…Summary Background Anti‐drug antibodies can be elicited by infliximab and adalimumab, but the rate of their decay after therapy is stopped is unknown. Aim To…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9

    Severe hepatocytotoxicity linked to denosumab by Malnick, S, Maor, Y, Melzer, E, Ziv-Sokolowskaia, N N, Neuman, M G

    “…Denosumab (Prolia, Amgen, Thousand Oaks, CA, USA) is a fully human antibody to the receptor activator of nuclear factor-KB ligand (RANKL). We present a case of…”
    Get more information
    Journal Article
  10. 10

    hVISA and MRSA endocarditis: an 8-year experience in a tertiary care centre by Maor, Y., Belausov, N., Ben-David, D., Smollan, G., Keller, N., Rahav, G.

    Published in Clinical microbiology and infection (01-10-2014)
    “…It is not clear if patients with heterogeneous intermediate resistance to vancomycin (hVISA) infectious endocarditis (IE) differ from methicillin-resistant S…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13

    The relation between objective and subjective impairment in cognitive function among multiple sclerosis patients – the role of depression by Maor, Y., Olmer, L., Mozes, B.

    Published in Multiple sclerosis (01-04-2001)
    “…To evaluate the relations between perceived cognitive function and objective cognitive deficit and to assess variables affecting perceived cognitive function…”
    Get full text
    Journal Article
  14. 14

    Genetic polymorphism of IL28B in hepatitis C-infected haemophilia patients in Israel by Maor, Y., Morali, G., Bashari, D., Pénaranda, G., Schapiro, J. M., Martinowitz, U., Halfon, P.

    “…Summary Single‐nucleotide polymorphisms (SNPs) near the IL28B gene were identified as major predictors of treatment response (sustained virologic response –…”
    Get full text
    Journal Article
  15. 15

    Stabilization of the bioactivity of tumor necrosis factor by its soluble receptors by ADERKA, D, ENGELMANN, H, MAOR, Y, BRAKEBUSCH, C, WALLACH, D

    Published in The Journal of experimental medicine (01-02-1992)
    “…The receptors for tumor necrosis factor (TNF) exist in cell-associated as well as soluble forms, both binding specifically to TNF. Since the soluble forms of…”
    Get full text
    Journal Article
  16. 16

    Fibrotest or Fibroscan for evaluation of liver fibrosis in haemophilia patients infected with hepatitis C by MAOR, Y., HALFON, P., BASHARI, D., PÉNARANDA, G., MORALI, G., KLAR, R., BAR-MEIR, S., MARTINOWITZ, U., OREN, R.

    “…Non‐invasive modalities to estimate fibrosis stage are desirable in hepatitis C‐infected haemophilia patients. Previous studies found a high rate of…”
    Get full text
    Journal Article
  17. 17

    Non-invasive biomarkers of liver fibrosis in haemophilia patients with hepatitis C: can you avoid liver biopsy? by MAOR, Y., BASHARI, D., KENET, G., LUBETSKY, A., LUBOSHITZ, J., SCHAPIRO, J. M., PÉNARANDA, G., BAR-MEIR, S., MARTINOWITZ, U., HALFON, P.

    “…Introduction:  Liver biopsy remains the gold standard for the evaluation of fibrosis despite its risks and limitations, especially in haemophilia patients…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Treatment of hepatitis C in patients with haemophilia - the Israeli National Hemophilia Center experience by MAOR, Y., SCHAPIRO, J. M., BASHARI, D., LURIE, Y., SAFADI, R., SEGOL, O., PARITSKY, M., RACHLIS, Z., AVIDAN, B., BAR-MEIR, S., MARTINOWITZ, U.

    “…Treatment with pegylated interferon (Peg‐IFN) and ribavirin, now the standard of care, has been shown to achieve sustained viral response (SVR) in up to 60% of…”
    Get full text
    Journal Article
  20. 20

    The competing effects of disease states on quality of life of the elderly: the case of urinary symptoms in men by Shmueli, Amir, Maor, Y

    Published in Quality of life research (01-01-1999)
    “…During the period 1993-1994 we conducted a study in Israel on a national-based sample of 960 men to examine the relationships between urinary symptoms and…”
    Get full text
    Journal Article